Department of Clinical Hematology, Dayanand Medical College and Hospital, Ludhiana, India.
Department of Cardiovascular & Thoracic Surgery, Dayanand Medical College and Hospital, Unit Hero DMC Heart Institute, Ludhiana, India.
Indian Heart J. 2021 May-Jun;73(3):336-341. doi: 10.1016/j.ihj.2021.02.006. Epub 2021 Feb 17.
Venous thromboembolism (VTE) is a major cause of mortality and morbidity worldwide. This study describes a real-world scenario of VTE presenting to a tertiary care hospital in India.
All patients presenting with acute VTE or associated complications from January 2017 to January 2020 were included in the study.
A total of 330 patient admissions related to VTE were included over 3 years, of which 303 had an acute episode of VTE. The median age was 50 years (IQR 38-64); 30% of patients were younger than 40 years of age. Only 24% of patients had provoked VTE with recent surgery (56%) and malignancy (16%) being the commonest risk factors. VTE manifested as isolated DVT (56%), isolated pulmonary embolism (PE; 19.1%), combined DVT/PE (22.4%), and upper limb DVT (2.3%). Patients with PE (n = 126) were classified as low-risk (15%), intermediate-risk (55%) and high-risk (29%). Reperfusion therapy was performed for 15.7% of patients with intermediate-risk and 75.6% with high-risk PE. In-hospital mortality for the entire cohort was 8.9%; 35% for high-risk PE and 11% for intermediate-risk PE. On multivariate analysis, the presence of active malignancy (OR = 5.8; 95% CI: 1.1-30.8, p = 0.038) and high-risk PE (OR = 4.8; 95% CI: 1.6-14.9, p = 0.006) were found to be independent predictors of mortality.
Our data provides real-world perspectives on the demographic sand management of patients presenting with acute VTE in a referral hospital setting. We observed relatively high mortality for intermediate-risk PE, necessitating better subclassification of this group to identify candidates for more aggressive approaches.
静脉血栓栓塞症(VTE)是全球范围内导致死亡和发病的主要原因。本研究描述了印度一家三级保健医院出现的静脉血栓栓塞症的真实情况。
本研究纳入了 2017 年 1 月至 2020 年 1 月期间因急性 VTE 或相关并发症就诊的所有患者。
3 年来共收治了 330 例与 VTE 相关的住院患者,其中 303 例为急性 VTE 发作。中位年龄为 50 岁(IQR 38-64);30%的患者年龄小于 40 岁。仅有 24%的患者存在近期手术(56%)和恶性肿瘤(16%)等明确诱因。VTE 表现为单纯性深静脉血栓形成(56%)、单纯性肺栓塞(19.1%)、深静脉血栓形成/肺栓塞(22.4%)和上肢深静脉血栓形成(2.3%)。有肺栓塞(n=126)的患者分为低危(15%)、中危(55%)和高危(29%)。对中危和高危肺栓塞患者分别进行了 15.7%和 75.6%的再灌注治疗。全队列住院死亡率为 8.9%;高危肺栓塞组为 35%,中危肺栓塞组为 11%。多因素分析显示,活动性恶性肿瘤(OR=5.8;95%CI:1.1-30.8,p=0.038)和高危肺栓塞(OR=4.8;95%CI:1.6-14.9,p=0.006)是死亡的独立预测因素。
本研究数据提供了在转诊医院环境下急性 VTE 患者的人口统计学和管理的真实情况。我们观察到中危肺栓塞患者的死亡率相对较高,这需要对该组患者进行更好的亚分类,以确定更积极治疗方法的候选人群。